Evidence

Trust the evidence, not the hype.

JetBio is moving from funded research and university deployments towards commercial validation. This page separates what is demonstrated today from what must still be proven for a repeatable product.

Researchers gathered around a JetBio system during a university collaboration

Research deployment programme

Application learning in three university settings.

The 3D-IV programme, backed by NC3Rs, supports development and application testing with Newcastle, Bristol and Cambridge universities.

Newcastle

Engineering and platform development

Research-led hardware, process and application development grounded in the technology’s Newcastle University origins.

Bristol

End-user workflow learning

A research deployment used to gather scientific and operational feedback for in vitro model development.

Cambridge

Application and environment learning

Collaborative research contributing to user requirements, application development and product definition.

Current status These are research deployments and application-development activities, not commercial sales.

JetBio researchers developing the printing system in a laboratory

Technology foundations

Research depth, directed towards a usable product.

JetBio was established to commercialise ReJI bioprinting technology developed through Newcastle University research. Detailed IP status is provided through controlled technical and investor diligence.

The commercial task now is to turn technical potential into documented, repeatable workflows with clear performance claims, specifications, support and buyer value.

Newcastle University spinoutDistinctive ReJI processNC3Rs-backed development

Peer-reviewed foundations

Follow the evidence back to the methods.

JetBio now brings the ReJI research record into one publication library, with DOI links and plain-language summaries of what each paper studied.

Explore the publications

Evidence boundary

What is confirmed, and what comes next.

Confirmed today

  • Newcastle University spinout commercialising ReJI bioprinting
  • Research deployments in Newcastle, Bristol and Cambridge
  • NC3Rs-backed 3D in vitro model programme
  • Integrated ReJI, microvalve and inkjet development approach

Commercial proof in progress

  • Final frozen product specification and configuration
  • Application-specific reproducibility and performance datasets
  • Customer-contracted pilots, purchase orders and commercial references
  • Final pricing, service model, labelling and regulatory classification

Letters of interest and research collaborations indicate demand and relevance. They are not represented as orders, revenue or completed commercial sales.

See the commercialisation case

Start a useful conversation

Help define the evidence your team would need.

A useful feasibility project starts with the decision criteria, not the demonstration. Tell us what proof would make JetBio credible in your workflow.

Discuss your model